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Background
In a single-center study published more than a decade ago
involving patients presenting to the emergency depart-
ment with severe sepsis and septic shock, mortality was
markedly lower among those who were treated according
to a 6-h protocol of early goal-directed therapy (EGDT),
in which intravenous fluids, vasopressors, inotropes, and
blood transfusions were adjusted to reach central hemo-
dynamic targets including central venous pressure, central
venous oxygen saturation, and indirect estimates of car-
diac output, than among those receiving usual care.
Methods
Objective: The objective was to determine whether these
EGDT findings were generalizable and whether all aspects
of the EGDT protocol were necessary to achieve those
outcomes.
Design: A multicenter randomized three-arm controlled
trial.
Setting: Thirty-one academic emergency departments in
the United States.
Subjects: Patients older than 18 years of age presenting to
the emergency department with septic shock.
Intervention: Patients were assigned to one of three
groups for 6 h of resuscitation: protocol-based EGDT as
defined by River and colleagues; protocol-based standard* Correspondence: pinskymr@upmc.edu
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creativecommons.org/publicdomain/zero/1.0/therapy that did not require the placement of a central
venous catheter, administration of inotropes, or blood
transfusions; and usual care which mandated no specific
monitoring or management approaches.
Outcomes: The primary end point was 60-day in-hospital
mortality. Also tested sequentially was whether protocol-
based care (EGDTand standard therapy groups combined)
was superior to usual care and whether protocol-based
EGDT was superior to protocol-based standard therapy.
Secondary outcomes included longer-term mortality and
the need for organ support.
Results
A total of 1,351 patients were enrolled, of whom 1,341
were evaluable due to patient/family request: 439 were
randomly assigned to protocol-based EGDT, 446 to
protocol-based standard therapy, and 456 to usual care.
Resuscitation strategies differed significantly with respect
to the monitoring of central venous pressure and central
venous oxygen and the use of intravenous fluids, vasopres-
sors, inotropes, and blood transfusions. By 60 days, there
were 92 deaths in the protocol-based EGDT group
(21.0 %), 81 in the protocol-based standard therapy
group (18.2 %), and 86 in the usual care group (18.9 %)
(relative risk with protocol-based therapy versus usual
care, 1.04; 95 % confidence interval, 0.82 to 1.31; P = 0.83;
relative risk with protocol-based EGDT versus protocol-
based standard therapy, 1.15; 95 % CI, 0.88 to 1.51; P =
0.31). There were no significant differences in 90-day mor-
tality, 1-year mortality, or the need for organ support.
Conclusions
In a multicenter trial conducted in the tertiary care
setting, protocol-based resuscitation of patients in whom
septic shock was diagnosed in the emergency department
did not improve outcomes.ccess article distributed under the terms of the Creative Commons Attribution
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Septic shock is the leading cause of mortality in patients
admitted to the ICU [1, 2]. In the United States alone
there are over 750,000 cases of severe sepsis and septic
shock each year [3]. Although the mortality associated with
severe sepsis and septic shock 12 years ago was ~30 %, epi-
demiological studies show that sepsis short-term mortality
has steadily decreased to just over 18 % today [4–6]. In a
2001 single-center randomized controlled trial published
by Rivers and colleagues, however, early goal-directed ther-
apy (EGDT) versus standard therapy significantly lowered
mortality (30.5 % versus 46.5 %) [7]. Primarily based on
this single-center trial, both the Society of Critical Care
Medicine and the European Society of Intensive Care
Medicine published guidelines in 2004, later updating
them in 2008 and 2012, all recommending protocol-based
care for severe sepsis, including EGDT. Importantly, a
fundamental component of the EGDT guidelines is the
insertion of a central venous catheter (CVC) to monitor
central venous pressure and central venous oxygen sat-
uration (ScvO2) to guide the use of intravenous fluids,
as well as the use of vasopressors, packed red blood cell
transfusions, and dobutamine to achieve prespecified
mean arterial pressure, central venous pressure, and
ScvO2 goals. However, questions remained as to which
elements of EGDTaccounted for this reduction in mortality
and whether or not a simpler more pragmatic approach
could yield similar outcome benefits.
In the ProCESS trial, investigators at 31 US academic
emergency departments randomized 1,351 patients (1,341
enrolled), age ≥18 years, presenting with septic shock to
one of three arms for 6 h of resuscitation: protocol-based
EGDT; protocol-based standard therapy not requiring the
insertion of a CVC; and usual care (wild-type). In the
protocol-based EGDT group, the resuscitation team
followed a protocol which mimicked that used by Rivers
and colleagues (CVC insertion, monitoring of central
venous pressure and ScvO2, intravenous fluids, pressors,
inotropes, and blood transfusions) [7]. The protocol-based
standard therapy called for the administration of intraven-
ous fluids to be titrated to achieve systolic blood pressure
and Shock Index (defined as the ratio of heart rate to sys-
tolic blood pressure) parameters while monitoring for
clinical symptoms of fluid overload. Importantly, the use
of a CVC was not required unless needed for venous
access and patients received packed red blood cell
transfusions only if the hemoglobin level was <7.5 g/dl.
In the usual care group, bedside providers directed all
care; and since there was no protocol to follow, all deci-
sions were left to the treating physician.
The primary outcome of the study was all-cause in-
hospital mortality at 60 days. The 60-day in-hospital
mortality for the combined protocol-based groups (19.5 %)
did not differ significantly from that in the usual caregroup (18.2 %) (relative risk, 1.04; 95 % confidence inter-
val, 0.82 to 1.31; P = 0.83), nor did mortality differ signifi-
cantly when the groups were compared separately.
Likewise, there were no significant differences in 90-day
mortality or in the time to death up to 90 days and 1 year
amongst the three groups. Importantly, both the protocol-
based standard care and the usual care groups received
fewer CVCs than the protocol-based EGDT group (56.5 %,
57.9 %, and 93.2 % respectively). These data suggest that
in the setting of a well-staffed tertiary care emergency
department that closely assesses the clinical status of pa-
tients in septic shock, using a defined protocolized ap-
proach did not alter outcome.
The obvious strengths of this study are that it was a
multicenter randomized controlled trial not a single-
center trial, and that with 1,341 enrollees this study was
five times the size of Rivers and colleagues’ trial. In
addition, the investigators in the ProCESS trial thor-
oughly monitored protocol adherence.
As with all clinical trials, there were some specific limi-
tations. The investigators excluded pregnant patients and
those with advanced AIDS from the study, two groups of
patients that often present with severe infections. The
results therefore do not aid the emergency medicine phys-
ician or intensivist when managing these two important
subgroups. Similarly, because the study was carried out in
tertiary academic emergency departments, concerns re-
main as to its applicability in community emergency
departments, urgent care centers, and on general med-
ical wards. This concern is highlighted by the fact that,
even in the usual care group, patients received on aver-
age 2.1 l intravenous fluids prior to randomization and
another 2.3 l from randomization to the 6-h mark. Are
most community emergency departments in the United
States providing 4.4 l intravenous fluids in the first 6 to
8 h after the detection of septic shock to their patients?
The answer to this question remains unknown.
It is worth mentioning that this study does not under-
mine the one published by Rivers and colleagues, which
brought a consciousness of early recognition and aggres-
sive management to patients with septic shock. Indeed, a
recent retrospective analysis of severe sepsis mortality
underscores the progressive reduction in sepsis mortality
over the past 12 years without the introduction of a single
new treatment other than protocolized care centered
around early recognition and management of severe
sepsis [6]. Those principles are still valid today. This is
also apparent in the ProCESS trial, where the mortality
in all groups was much lower than that seen in Rivers
and colleagues’ treatment or control arms. Importantly,
patients in the ProCESS trial were rapidly identified as
having severe sepsis/septic shock and treated with a
bolus of intravenous fluids and intravenous antibiotics
prior to enrollment in the resuscitation arms. Thus,
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algorithm are unnecessary (CVC insertion, continuous
ScvO2 monitoring, dobutamine, and transfusion triggers
for hematocrit <30 %), it does substantiate that prompt
recognition coupled with resuscitation, administration of
antibiotics, and source control are the cornerstones for
the treatment of septic shock.
So are we now ready to adapt a protocol-less approach
to the management of patients with septic shock? Some
specific conclusions can be drawn from the ProCESS
trial that are further substantiated by the recent publi-
cations of two other sepsis trials – the Australasian
Resuscitation in Sepsis Evaluation (ARISE) trial [8] and
the Protocolised Management in Sepsis (ProMISE) trial
[9] – and in general confirm the finding of no difference
in patient-centered outcomes between EGDT and usual
care. First, continuous ScvO2 monitoring is unwarranted
as a universal requirement [10]; this is supported by the
fact that in the ProCESS trial the ICU admission rate was
approximately 5 % less for the two non-EGDT groups
without this monitoring technique than for the protocol-
based EGDT group. Similarly, CVC insertion should be
individualized, as should decisions about the transfusion
threshold. It remains to be seen what the cost-saving impli-
cations will be for the healthcare system moving forward.
Recommendation
Based on the results of this large multicenter random-
ized controlled trial, patients presenting with septic
shock at academic emergency departments in the USA
can be safely managed with a protocol-less approach
that focuses on patient response to routine resuscitation
management, early antibiotic use, and close observation.
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